Buserelin (Suprefact)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 11:51, 23 September 2023 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis.

Diseases for which it is used

History of changes in EMA indication

  • 1984-08-16: EURD

Also known as

  • Code names: HOE-766, ICI-123215, S74-6766
  • Brand names: Bigonist, Etilamide, Profact, Receptal, Suprecur, Suprefact
Retrieved from "https://hemonc.org/w/index.php?title=Buserelin_(Suprefact)&oldid=78103"